USFDA grants nod for Caplin Steriles Ofloxacin Ophthalmic Solution Ruchika Sharma16 April 2024 1:30 PM ISTOfloxacin Ophthalmic Solution USP 0.3% is indicated for treatment of eye infections caused during the conditions of conjunctivitis and corneal ulcers.
Viatris names Corinne Le Goff as Chief Commercial Officer Ruchika Sharma16 April 2024 12:30 PM ISTPittsburgh: Viatris Inc., a global healthcare company, has announced that Corinne Le Goff has joined the company as Chief Commercial Officer...
IIT Madras unveils India's first mobile Medical Devices Calibration facility Kajal Rajput16 April 2024 11:30 AM ISTThe infrastructure available in this mobile unit include state-of-the-art equipment to test the safety of medical devices and their functionalities as...
Dr Reddy's Swiss to sell entire stake in Dr Reddy's Venezuela C.A. Ruchika Sharma15 April 2024 5:38 PM ISTHyderabad: Through a recent BSE filing, Dr Reddy's Labs has informed that the wholly owned subsidiary of the Company, namely, Dr...
Innate Pharma announces advancement of Sanofi-developed NK Cell Engager SAR443579/ IPH6101 progressing to Phase 2 for blood cancer patients Ruchika Sharma15 April 2024 3:17 PM ISTFrance: Innate Pharma SA has announced that the first patient was dosed in the Phase 2 dose expansion part of the Sanofi-sponsored clinical trial...
Glenmark Pharma recalls 6528 bottles of BP drug in US Ruchika Sharma15 April 2024 1:36 PM ISTNew Delhi: Glenmark Pharmaceuticals is recalling 6,528 bottles of a medication prescribed for the treatment of high blood pressure in the...
Nigeria rolls out new 5-in-1 vaccine against meningitis Ruchika Sharma15 April 2024 12:36 PM ISTThis new multivalent conjugate vaccine was 13 years in the making and was based on a partnership between PATH and the Serum Institute of India.
CDSCO Panel Approves J&J's Protocol Amendment Proposal For Amivantamab, Lazertinib combination Dr. Divya Colin14 April 2024 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
CDSCO Panel Approves Roche's Protocol Amendment Proposal For Anti-cancer Drug Atezolizumab, Lenvatinib, and Sorafenib Study Dr. Divya Colin14 April 2024 5:15 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
Bayer AG arm AskBio names Mansuo Shannon as Chief Scientific Officer Ruchika Sharma14 April 2024 1:00 PM ISTResearch Triangle Park: Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, has...
Arvinas, Novartis collaborate for development, commercialization of ARV-766 for prostate cancer Ruchika Sharma14 April 2024 10:00 AM ISTNew Haven: Arvinas, Inc., a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, has...
Lupin Gets CDSCO Panel Nod to Study Glycopyrronium Bromide, Vilanterol Trifenatate powder for inhalation in capsule Dr. Divya Colin13 April 2024 5:30 PM ISTNew Delhi: Reviewing the Phase IV clinical trial protocol of Lupin's pulmonary FDC (Fixed Dose Combination) Glycopyrronium Bromide plus Vilanterol...
